Previous close | 4.5100 |
Open | 4.5400 |
Bid | 4.3900 x 300 |
Ask | 4.4700 x 200 |
Day's range | 4.4250 - 4.6300 |
52-week range | 1.5000 - 5.3900 |
Volume | |
Avg. volume | 2,256,753 |
Market cap | 3.117B |
Beta (5Y monthly) | -1.13 |
PE ratio (TTM) | 11.68 |
EPS (TTM) | 0.3800 |
Earnings date | 07 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 6.67 |
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript May 1, 2024 Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. SMMT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies […]
Explore key takeaways from Summit Therapeutics' Q1 2024 earnings, including robust financial positioning and pivotal clinical advancements.
Q1 2024 Summit Therapeutics Inc Earnings Call